Bayesian Capital Management’s Chemours CC Stock Holding History

Bayesian Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-62,600	Closed	-$717K	–	562
2025 Q2	$717K	Buy	+62,600	New	+$705K	0.11%	230
2025 Q1	–	Sell	-52,510	Closed	-$887K	–	645
2024 Q4	$887K	Buy	+52,510	New	+$1.02M	0.11%	252
2024 Q1	–	Sell	-7,214	Closed	-$228K	–	805
2023 Q4	$228K	Buy	+7,214	New	+$196K	0.02%	569
2022 Q3	–	Sell	-20,818	Closed	-$667K	–	727
2022 Q2	$667K	Buy	+20,818	New	+$766K	0.12%	249
2020 Q3	–	Sell	-14,671	Closed	-$225K	–	531
2020 Q2	$225K	Sell	14,671 -38,400	-72%	-$485K	0.05%	416
2020 Q1	$471K	Buy	+53,071	New	+$765K	0.1%	307
2018 Q4	–	Sell	-9,224	Closed	-$364K	–	626
2018 Q3	$364K	Sell	9,224 -4,800	-34%	-$210K	0.06%	402
2018 Q2	$622K	Sell	14,024 -5,076	-27%	-$253K	0.14%	215
2018 Q1	$930K	Buy	+19,100	New	+$955K	0.24%	134
2017 Q3	–	Sell	-7,800	Closed	-$296K	–	491
2017 Q2	$296K	Buy	+7,800	New	+$308K	0.11%	292
2017 Q1	–	Sell	-30,700	Closed	-$678K	–	434
2016 Q4	$678K	Buy	+30,700	New	+$630K	0.17%	232

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bayesian Capital Management's CC Position: Q3 2025 in Review

Bayesian Capital Management sold out of Chemours (CC) in Q3 2025, closing a stake of 62,600 shares — an estimated $717K sold.

Bayesian Capital Management first reported a position in CC in Q4 2016 and held it in 11 quarters. The position peaked at $930K in Q1 2018. 428 funds tracked by Wall St. Rank hold CC as of Q3 2025.

Bayesian Capital Management reported no remaining Chemours position as of Q3 2025 after selling out during the quarter.
Bayesian Capital Management sold 62,600 Chemours shares in Q3 2025, an estimated $717K.
Bayesian Capital Management first reported a position in Chemours in Q4 2016 and held it in 11 quarters.
Bayesian Capital Management's Chemours position peaked at $930K in Q1 2018.
428 funds tracked by Wall St. Rank held Chemours as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.